Details
Stereochemistry | ACHIRAL |
Molecular Formula | 4Na.O7P2.10H2O |
Molecular Weight | 446.0552 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
O.O.O.O.O.O.O.O.O.O.[Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O
InChI
InChIKey=VZWGHDYJGOMEKT-UHFFFAOYSA-J
InChI=1S/4Na.H4O7P2.10H2O/c;;;;1-8(2,3)7-9(4,5)6;;;;;;;;;;/h;;;;(H2,1,2,3)(H2,4,5,6);10*1H2/q4*+1;;;;;;;;;;;/p-4
DescriptionSources: https://books.google.ru/books?id=cPjjBwAAQBAJ&printsec=frontcover&hl=ru#v=onepage&q&f=falseCurator's Comment: Description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/11401820 | https://www.ncbi.nlm.nih.gov/pubmed/27061894 | http://www.food-info.net/uk/e/e450.htm
Sources: https://books.google.ru/books?id=cPjjBwAAQBAJ&printsec=frontcover&hl=ru#v=onepage&q&f=false
Curator's Comment: Description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/11401820 | https://www.ncbi.nlm.nih.gov/pubmed/27061894 | http://www.food-info.net/uk/e/e450.htm
Inorganic pyrophosphate (PPi ) has long been known as a by-product of many intracellular biosynthetic reactions. PPi plays the regulatory role in living systems, such as activities of enzymes, fidelity of syntheses of macromolecules, and proliferation of cells. PPi is used as a biochemical energy source instead of ATP especially in bacteria, protists, and plants. PPi may also regulate the formation and dissolution of bone as well as pathologic calcification of soft tissues and the formation of urinary stones. The formation of calcium pyrophosphate dihydrate crystals in the extracellular fluids of joints cause the disease called pseudogout. Sodium, potassium and calcium pyrophosphates (E450) are used as food additives as buffers and emulsifiers.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: GO:0030282 Sources: https://www.ncbi.nlm.nih.gov/pubmed/27061894 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Diagnostic | Stannous Pyrophosphate Approved Usehttps://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=30046b6b-09ea-46b1-8e60-61c53e1e7282 |
|||
Diagnostic | Stannous Pyrophosphate Approved Usehttps://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=30046b6b-09ea-46b1-8e60-61c53e1e7282 |
|||
Diagnostic | Stannous Pyrophosphate Approved Usehttps://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=30046b6b-09ea-46b1-8e60-61c53e1e7282 |
PubMed
Title | Date | PubMed |
---|---|---|
Pyrophosphate analogues as inhibitors of herpes simplex virus type 1 DNA polymerase. | 1980 Mar 28 |
|
Nucleoside triphosphates promote the transformation of Ah receptor to its DNA-binding form. | 1991 Mar 1 |
|
Biochemical characterization of HIV-1 reverse transcriptases encoding mutations at amino acid residues 161 and 208 involved in resistance to phosphonoformate. | 1998 Dec 15 |
|
Structure-activity relationships among the nitrogen containing bisphosphonates in clinical use and other analogues: time-dependent inhibition of human farnesyl pyrophosphate synthase. | 2008 Apr 10 |
Sample Use Guides
In Vivo Use Guide
Sources: http://www.food-info.net/uk/e/e450.htm
Acceptable Daily Intake: Up to 70 mg/kg bodyweight for all pyrophosphate containing food additives
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/6155110
pyrophosphoric acid at the concentration of 0.1 - 1.0 mM does not affect spore germination of Streptomyces galilaeus ATCC 31133.
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
100000087357
Created by
admin on Fri Dec 15 17:35:56 GMT 2023 , Edited by admin on Fri Dec 15 17:35:56 GMT 2023
|
PRIMARY | |||
|
IY3DKB96QW
Created by
admin on Fri Dec 15 17:35:56 GMT 2023 , Edited by admin on Fri Dec 15 17:35:56 GMT 2023
|
PRIMARY | |||
|
3084150
Created by
admin on Fri Dec 15 17:35:56 GMT 2023 , Edited by admin on Fri Dec 15 17:35:56 GMT 2023
|
PRIMARY | |||
|
SUB23261
Created by
admin on Fri Dec 15 17:35:56 GMT 2023 , Edited by admin on Fri Dec 15 17:35:56 GMT 2023
|
PRIMARY | |||
|
IY3DKB96QW
Created by
admin on Fri Dec 15 17:35:56 GMT 2023 , Edited by admin on Fri Dec 15 17:35:56 GMT 2023
|
PRIMARY | |||
|
DTXSID50158904
Created by
admin on Fri Dec 15 17:35:56 GMT 2023 , Edited by admin on Fri Dec 15 17:35:56 GMT 2023
|
PRIMARY | |||
|
13472-36-1
Created by
admin on Fri Dec 15 17:35:56 GMT 2023 , Edited by admin on Fri Dec 15 17:35:56 GMT 2023
|
PRIMARY | |||
|
1944687
Created by
admin on Fri Dec 15 17:35:56 GMT 2023 , Edited by admin on Fri Dec 15 17:35:56 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD